MED13_HUMAN - dbPTM
MED13_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MED13_HUMAN
UniProt AC Q9UHV7
Protein Name Mediator of RNA polymerase II transcription subunit 13
Gene Name MED13
Organism Homo sapiens (Human).
Sequence Length 2174
Subcellular Localization Nucleus.
Protein Description Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors..
Protein Sequence MSASFVPNGASLEDCHCNLFCLADLTGIKWKKYVWQGPTSAPILFPVTEEDPILSSFSRCLKADVLGVWRRDQRPGRRELWIFWWGEDPSFADLIHHDLSEEEDGVWENGLSYECRTLLFKAVHNLLERCLMNRNFVRIGKWFVKPYEKDEKPINKSEHLSCSFTFFLHGDSNVCTSVEINQHQPVYLLSEEHITLAQQSNSPFQVILCPFGLNGTLTGQAFKMSDSATKKLIGEWKQFYPISCCLKEMSEEKQEDMDWEDDSLAAVEVLVAGVRMIYPACFVLVPQSDIPTPSPVGSTHCSSSCLGVHQVPASTRDPAMSSVTLTPPTSPEEVQTVDPQSVQKWVKFSSVSDGFNSDSTSHHGGKIPRKLANHVVDRVWQECNMNRAQNKRKYSASSGGLCEEATAAKVASWDFVEATQRTNCSCLRHKNLKSRNAGQQGQAPSLGQQQQILPKHKTNEKQEKSEKPQKRPLTPFHHRVSVSDDVGMDADSASQRLVISAPDSQVRFSNIRTNDVAKTPQMHGTEMANSPQPPPLSPHPCDVVDEGVTKTPSTPQSQHFYQMPTPDPLVPSKPMEDRIDSLSQSFPPQYQEAVEPTVYVGTAVNLEEDEANIAWKYYKFPKKKDVEFLPPQLPSDKFKDDPVGPFGQESVTSVTELMVQCKKPLKVSDELVQQYQIKNQCLSAIASDAEQEPKIDPYAFVEGDEEFLFPDKKDRQNSEREAGKKHKVEDGTSSVTVLSHEEDAMSLFSPSIKQDAPRPTSHARPPSTSLIYDSDLAVSYTDLDNLFNSDEDELTPGSKKSANGSDDKASCKESKTGNLDPLSCISTADLHKMYPTPPSLEQHIMGFSPMNMNNKEYGSMDTTPGGTVLEGNSSSIGAQFKIEVDEGFCSPKPSEIKDFSYVYKPENCQILVGCSMFAPLKTLPSQYLPPIKLPEECIYRQSWTVGKLELLSSGPSMPFIKEGDGSNMDQEYGTAYTPQTHTSFGMPPSSAPPSNSGAGILPSPSTPRFPTPRTPRTPRTPRGAGGPASAQGSVKYENSDLYSPASTPSTCRPLNSVEPATVPSIPEAHSLYVNLILSESVMNLFKDCNFDSCCICVCNMNIKGADVGVYIPDPTQEAQYRCTCGFSAVMNRKFGNNSGLFLEDELDIIGRNTDCGKEAEKRFEALRATSAEHVNGGLKESEKLSDDLILLLQDQCTNLFSPFGAADQDPFPKSGVISNWVRVEERDCCNDCYLALEHGRQFMDNMSGGKVDEALVKSSCLHPWSKRNDVSMQCSQDILRMLLSLQPVLQDAIQKKRTVRPWGVQGPLTWQQFHKMAGRGSYGTDESPEPLPIPTFLLGYDYDYLVLSPFALPYWERLMLEPYGSQRDIAYVVLCPENEALLNGAKSFFRDLTAIYESCRLGQHRPVSRLLTDGIMRVGSTASKKLSEKLVAEWFSQAADGNNEAFSKLKLYAQVCRYDLGPYLASLPLDSSLLSQPNLVAPTSQSLITPPQMTNTGNANTPSATLASAASSTMTVTSGVAISTSVATANSTLTTASTSSSSSSNLNSGVSSNKLPSFPPFGSMNSNAAGSMSTQANTVQSGQLGGQQTSALQTAGISGESSSLPTQPHPDVSESTMDRDKVGIPTDGDSHAVTYPPAIVVYIIDPFTYENTDESTNSSSVWTLGLLRCFLEMVQTLPPHIKSTVSVQIIPCQYLLQPVKHEDREIYPQHLKSLAFSAFTQCRRPLPTSTNVKTLTGFGPGLAMETALRSPDRPECIRLYAPPFILAPVKDKQTELGETFGEAGQKYNVLFVGYCLSHDQRWILASCTDLYGELLETCIINIDVPNRARRKKSSARKFGLQKLWEWCLGLVQMSSLPWRVVIGRLGRIGHGELKDWSCLLSRRNLQSLSKRLKDMCRMCGISAADSPSILSACLVAMEPQGSFVIMPDSVSTGSVFGRSTTLNMQTSQLNTPQDTSCTHILVFPTSASVQVASATYTTENLDLAFNPNNDGADGMGIFDLLDTGDDLDPDIINILPASPTGSPVHSPGSHYPHGGDAGKGQSTDRLLSTEPHEEVPNILQQPLALGYFVSTAKAGPLPDWFWSACPQAQYQCPLFLKASLHLHVPSVQSDELLHSKHSHPLDSNQTSDVLRFVLEQYNALSWLTCDPATQDRRSCLPIHFVVLNQLYNFIMNML
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
56PhosphorylationEEDPILSSFSRCLKA
CCCCHHHHHHHHHHC
24.6424945436
70MethylationADVLGVWRRDQRPGR
CHHHEEEECCCCCCC
29.8654560319
225O-linked_GlycosylationTGQAFKMSDSATKKL
CCCEEECCHHHHHHH
29.0730379171
227O-linked_GlycosylationQAFKMSDSATKKLIG
CEEECCHHHHHHHHH
30.4530379171
229O-linked_GlycosylationFKMSDSATKKLIGEW
EECCHHHHHHHHHHH
32.4430379171
237AcetylationKKLIGEWKQFYPISC
HHHHHHHHHHHHHHH
26.6526051181
240PhosphorylationIGEWKQFYPISCCLK
HHHHHHHHHHHHHHH
9.36-
243PhosphorylationWKQFYPISCCLKEMS
HHHHHHHHHHHHHCC
8.35-
321PhosphorylationSTRDPAMSSVTLTPP
CCCCCCCCEEEECCC
24.6230108239
322PhosphorylationTRDPAMSSVTLTPPT
CCCCCCCEEEECCCC
13.1630108239
324PhosphorylationDPAMSSVTLTPPTSP
CCCCCEEEECCCCCH
27.1930266825
326PhosphorylationAMSSVTLTPPTSPEE
CCCEEEECCCCCHHH
20.1830266825
329PhosphorylationSVTLTPPTSPEEVQT
EEEECCCCCHHHHCC
59.1130266825
330PhosphorylationVTLTPPTSPEEVQTV
EEECCCCCHHHHCCC
35.7730266825
336PhosphorylationTSPEEVQTVDPQSVQ
CCHHHHCCCCHHHHH
31.8630266825
341PhosphorylationVQTVDPQSVQKWVKF
HCCCCHHHHHHHEEC
31.7230108239
349PhosphorylationVQKWVKFSSVSDGFN
HHHHEECCCCCCCCC
24.90-
366AcetylationSTSHHGGKIPRKLAN
CCCCCCCCCCHHHHH
54.8825953088
366UbiquitinationSTSHHGGKIPRKLAN
CCCCCCCCCCHHHHH
54.88-
394PhosphorylationRAQNKRKYSASSGGL
HHHHCCCCCCCCCCC
17.3230266825
395PhosphorylationAQNKRKYSASSGGLC
HHHCCCCCCCCCCCC
25.3923401153
397PhosphorylationNKRKYSASSGGLCEE
HCCCCCCCCCCCCHH
24.4730266825
398PhosphorylationKRKYSASSGGLCEEA
CCCCCCCCCCCCHHH
36.2730266825
406PhosphorylationGGLCEEATAAKVASW
CCCCHHHHHHHHHCC
30.3523927012
445PhosphorylationGQQGQAPSLGQQQQI
CCCCCCCCHHHHHHH
48.4228555341
474PhosphorylationKPQKRPLTPFHHRVS
CCCCCCCCCCCCCCC
26.9630266825
481PhosphorylationTPFHHRVSVSDDVGM
CCCCCCCCCCCCCCC
18.8323911959
483PhosphorylationFHHRVSVSDDVGMDA
CCCCCCCCCCCCCCC
22.1625850435
494PhosphorylationGMDADSASQRLVISA
CCCCCCHHCEEEEEC
21.5627251275
500PhosphorylationASQRLVISAPDSQVR
HHCEEEEECCCCCEE
26.6925159151
504PhosphorylationLVISAPDSQVRFSNI
EEEECCCCCEEECCC
29.5225159151
513PhosphorylationVRFSNIRTNDVAKTP
EEECCCCCCCCCCCC
31.7928985074
519PhosphorylationRTNDVAKTPQMHGTE
CCCCCCCCCCCCCCC
14.7123927012
525PhosphorylationKTPQMHGTEMANSPQ
CCCCCCCCCCCCCCC
14.1223927012
530PhosphorylationHGTEMANSPQPPPLS
CCCCCCCCCCCCCCC
18.5123401153
537PhosphorylationSPQPPPLSPHPCDVV
CCCCCCCCCCCCCCC
27.2623401153
549PhosphorylationDVVDEGVTKTPSTPQ
CCCCCCCCCCCCCCC
39.8023663014
551PhosphorylationVDEGVTKTPSTPQSQ
CCCCCCCCCCCCCHH
17.0725159151
553PhosphorylationEGVTKTPSTPQSQHF
CCCCCCCCCCCHHCC
58.9320068231
554PhosphorylationGVTKTPSTPQSQHFY
CCCCCCCCCCHHCCC
26.9325849741
557PhosphorylationKTPSTPQSQHFYQMP
CCCCCCCHHCCCCCC
27.1620068231
561PhosphorylationTPQSQHFYQMPTPDP
CCCHHCCCCCCCCCC
11.1920068231
565PhosphorylationQHFYQMPTPDPLVPS
HCCCCCCCCCCCCCC
34.6720068231
572PhosphorylationTPDPLVPSKPMEDRI
CCCCCCCCCCHHHHH
41.7420068231
635PhosphorylationFLPPQLPSDKFKDDP
CCCCCCCCCCCCCCC
63.12-
687PhosphorylationQCLSAIASDAEQEPK
HHHHHHHCCCHHCCC
31.1025159151
698PhosphorylationQEPKIDPYAFVEGDE
HCCCCCCCCEECCCC
14.6627642862
712AcetylationEEFLFPDKKDRQNSE
CCCCCCCHHHCCCCH
57.7323236377
733PhosphorylationHKVEDGTSSVTVLSH
EECCCCCCCEEEECC
28.4829759185
734PhosphorylationKVEDGTSSVTVLSHE
ECCCCCCCEEEECCH
22.9629759185
736PhosphorylationEDGTSSVTVLSHEED
CCCCCCEEEECCHHH
20.0629759185
739PhosphorylationTSSVTVLSHEEDAMS
CCCEEEECCHHHHHH
25.2329759185
749PhosphorylationEDAMSLFSPSIKQDA
HHHHHHHCCCCCCCC
24.0317192257
815UbiquitinationKASCKESKTGNLDPL
CHHHHHCCCCCCCCC
62.64-
816PhosphorylationASCKESKTGNLDPLS
HHHHHCCCCCCCCCC
40.3523186163
823PhosphorylationTGNLDPLSCISTADL
CCCCCCCCCEEHHHH
18.1323186163
826PhosphorylationLDPLSCISTADLHKM
CCCCCCEEHHHHHHH
23.1325159151
827PhosphorylationDPLSCISTADLHKMY
CCCCCEEHHHHHHHC
12.3223186163
834PhosphorylationTADLHKMYPTPPSLE
HHHHHHHCCCCCCHH
14.5720068231
836PhosphorylationDLHKMYPTPPSLEQH
HHHHHCCCCCCHHHH
30.2820068231
839PhosphorylationKMYPTPPSLEQHIMG
HHCCCCCCHHHHHCC
45.8222496350
848PhosphorylationEQHIMGFSPMNMNNK
HHHHCCCCCCCCCCC
19.9420068231
857PhosphorylationMNMNNKEYGSMDTTP
CCCCCCCCCCCCCCC
18.9925627689
859PhosphorylationMNNKEYGSMDTTPGG
CCCCCCCCCCCCCCC
16.7525627689
862PhosphorylationKEYGSMDTTPGGTVL
CCCCCCCCCCCCEEE
26.6725159151
863PhosphorylationEYGSMDTTPGGTVLE
CCCCCCCCCCCEEEE
18.7017192257
867PhosphorylationMDTTPGGTVLEGNSS
CCCCCCCEEEECCCC
28.0328348404
890PhosphorylationEVDEGFCSPKPSEIK
EECCCCCCCCHHHCC
33.4329255136
892UbiquitinationDEGFCSPKPSEIKDF
CCCCCCCCHHHCCCC
44.90-
894PhosphorylationGFCSPKPSEIKDFSY
CCCCCCHHHCCCCCE
59.0730266825
901PhosphorylationSEIKDFSYVYKPENC
HHCCCCCEEECCCCC
14.0622210691
1005PhosphorylationAGILPSPSTPRFPTP
CCCCCCCCCCCCCCC
56.2121406692
1006PhosphorylationGILPSPSTPRFPTPR
CCCCCCCCCCCCCCC
23.1321406692
1011PhosphorylationPSTPRFPTPRTPRTP
CCCCCCCCCCCCCCC
23.77-
1014PhosphorylationPRFPTPRTPRTPRTP
CCCCCCCCCCCCCCC
20.51-
1017PhosphorylationPTPRTPRTPRTPRGA
CCCCCCCCCCCCCCC
20.5128985074
1020PhosphorylationRTPRTPRTPRGAGGP
CCCCCCCCCCCCCCC
20.6720068231
1022MethylationPRTPRTPRGAGGPAS
CCCCCCCCCCCCCCC
47.16115389153
1029PhosphorylationRGAGGPASAQGSVKY
CCCCCCCCCCCCEEE
25.0230266825
1033PhosphorylationGPASAQGSVKYENSD
CCCCCCCCEEECCCC
11.8930266825
1042PhosphorylationKYENSDLYSPASTPS
EECCCCCCCCCCCCC
20.0027732954
1043PhosphorylationYENSDLYSPASTPST
ECCCCCCCCCCCCCC
22.6827732954
1046PhosphorylationSDLYSPASTPSTCRP
CCCCCCCCCCCCCCC
44.2127732954
1047PhosphorylationDLYSPASTPSTCRPL
CCCCCCCCCCCCCCC
24.3027732954
1049PhosphorylationYSPASTPSTCRPLNS
CCCCCCCCCCCCCCC
39.9827732954
1050PhosphorylationSPASTPSTCRPLNSV
CCCCCCCCCCCCCCC
17.4627732954
1133SumoylationFSAVMNRKFGNNSGL
HHHHHCCCCCCCCCC
53.25-
1138PhosphorylationNRKFGNNSGLFLEDE
CCCCCCCCCCCEECH
40.65-
1157SumoylationGRNTDCGKEAEKRFE
CCCCCCCHHHHHHHH
61.14-
1247PhosphorylationRQFMDNMSGGKVDEA
HHHHHHCCCCCCCHH
51.12-
1363PhosphorylationERLMLEPYGSQRDIA
HHHCCCCCCCCCCEE
21.7529083192
1365PhosphorylationLMLEPYGSQRDIAYV
HCCCCCCCCCCEEEE
19.0529083192
1387PhosphorylationALLNGAKSFFRDLTA
HHHHHHHHHHHHHHH
29.1424719451
1393PhosphorylationKSFFRDLTAIYESCR
HHHHHHHHHHHHHHC
18.4620736484
1396PhosphorylationFRDLTAIYESCRLGQ
HHHHHHHHHHHCCCC
10.1820736484
1421PhosphorylationGIMRVGSTASKKLSE
CCHHCCCHHHHHHHH
29.08-
1423PhosphorylationMRVGSTASKKLSEKL
HHCCCHHHHHHHHHH
30.34-
1448UbiquitinationGNNEAFSKLKLYAQV
CCCHHHHHHHHHHHH
43.0921906983
1452PhosphorylationAFSKLKLYAQVCRYD
HHHHHHHHHHHHCCC
8.0620068231
1634PhosphorylationDGDSHAVTYPPAIVV
CCCCCCCCCCCEEEE
30.97-
1683PhosphorylationTLPPHIKSTVSVQII
HCCCCCCCCEEEEEE
33.18-
1684PhosphorylationLPPHIKSTVSVQIIP
CCCCCCCCEEEEEEE
16.29-
1686PhosphorylationPHIKSTVSVQIIPCQ
CCCCCCEEEEEEECC
14.37-
1694PhosphorylationVQIIPCQYLLQPVKH
EEEEECCHHHCCCCC
18.98-
1728PhosphorylationQCRRPLPTSTNVKTL
CCCCCCCCCCCCEEC
56.7320068231
1729PhosphorylationCRRPLPTSTNVKTLT
CCCCCCCCCCCEECC
18.9522210691
1730PhosphorylationRRPLPTSTNVKTLTG
CCCCCCCCCCEECCC
46.6520068231
1736PhosphorylationSTNVKTLTGFGPGLA
CCCCEECCCCCCCHH
35.3822210691
1746PhosphorylationGPGLAMETALRSPDR
CCCHHHHHHHHCCCC
20.2225159151
1750PhosphorylationAMETALRSPDRPECI
HHHHHHHCCCCCHHH
31.8125159151
1772UbiquitinationILAPVKDKQTELGET
EEEECCCCCCHHHHH
54.09-
1786UbiquitinationTFGEAGQKYNVLFVG
HHHHHHHHEEEEEEE
37.56-
1833PhosphorylationNRARRKKSSARKFGL
CHHHHHHHHHHHHHH
32.0624260401
1834PhosphorylationRARRKKSSARKFGLQ
HHHHHHHHHHHHHHH
40.7624260401
1837AcetylationRKKSSARKFGLQKLW
HHHHHHHHHHHHHHH
43.4230593069
1842AcetylationARKFGLQKLWEWCLG
HHHHHHHHHHHHHHH
61.6930593075
1887PhosphorylationLSRRNLQSLSKRLKD
HCHHHHHHHHHHHHH
37.4621815630
1889PhosphorylationRRNLQSLSKRLKDMC
HHHHHHHHHHHHHHH
22.4523401153
1890UbiquitinationRNLQSLSKRLKDMCR
HHHHHHHHHHHHHHH
68.02-
2018PhosphorylationIINILPASPTGSPVH
HHEECCCCCCCCCCC
22.5126074081
2020PhosphorylationNILPASPTGSPVHSP
EECCCCCCCCCCCCC
48.0426074081
2022PhosphorylationLPASPTGSPVHSPGS
CCCCCCCCCCCCCCC
26.6526074081
2026PhosphorylationPTGSPVHSPGSHYPH
CCCCCCCCCCCCCCC
31.0626074081
2029PhosphorylationSPVHSPGSHYPHGGD
CCCCCCCCCCCCCCC
24.1926074081
2031PhosphorylationVHSPGSHYPHGGDAG
CCCCCCCCCCCCCCC
9.9126074081
2042PhosphorylationGDAGKGQSTDRLLST
CCCCCCCCCCCCCCC
40.7328450419
2043PhosphorylationDAGKGQSTDRLLSTE
CCCCCCCCCCCCCCC
19.7625627689
2048PhosphorylationQSTDRLLSTEPHEEV
CCCCCCCCCCCCCCC
35.0027273156
2049PhosphorylationSTDRLLSTEPHEEVP
CCCCCCCCCCCCCCC
54.2128450419
2067PhosphorylationQQPLALGYFVSTAKA
HCCHHHCHHHHCCCC
11.1423186163
2070PhosphorylationLALGYFVSTAKAGPL
HHHCHHHHCCCCCCC
16.8523186163
2071PhosphorylationALGYFVSTAKAGPLP
HHCHHHHCCCCCCCC
27.2023186163

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseFBXW7Q969H0
PMID:23322298

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MED13_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MED13_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MED29_HUMANMED29physical
22939629
MED24_HUMANMED24physical
22939629
MED4_HUMANMED4physical
22939629
MED14_HUMANMED14physical
22939629
MED16_HUMANMED16physical
22939629
MED21_HUMANMED21physical
22939629
MED1_HUMANMED1physical
23563140
MED26_HUMANMED26physical
23563140
MED19_HUMANMED19physical
23563140
MED7_HUMANMED7physical
23563140
U5S1_HUMANEFTUD2physical
26344197
MED1_HUMANMED1physical
26344197
MED10_HUMANMED10physical
26344197
MED14_HUMANMED14physical
26344197
MED16_HUMANMED16physical
26344197
MED18_HUMANMED18physical
26344197
MED19_HUMANMED19physical
26344197
MED27_HUMANMED27physical
26344197
MED6_HUMANMED6physical
26344197
MED8_HUMANMED8physical
26344197
RBP2_HUMANRANBP2physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MED13_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; THR-329; TYR-394;SER-395; SER-481; SER-530; SER-537; SER-890; SER-1029 AND SER-2048,AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-504; THR-519 ANDSER-537, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; THR-336; SER-481;SER-500; THR-863; SER-890 AND SER-1029, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-890, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029, AND MASSSPECTROMETRY.

TOP